Please login to the form below

Not currently logged in
Email:
Password:

Swiss biotech Inositec appoints new chief medical officer

Dr Frits van Alphen joins the group from Roche

Zurich-based biotechnology company Inositec has appointed a new chief medical officer in the form of Dr Frits van Alphen.

He said: “As CMO of Inositec, I have the golden opportunity to utilise my broad experience and entrepreneurial mind-set to develop new medicines.

“These innovative products have the potential to significantly advance patient care in vascular and other calcification disorders, all with high unmet medical need.”

Dr van Alphen joins from Roche, where he headed its operational excellence team and prior to this he was chief medical officer at Vifor Pharma, head of medical affairs Europe at Novartis as well as heading their clinical operations team in the Netherlands.

Dr Mattias Ivarsson, chief medical officer of Inositec, said: “Dr van Alphen is a key addition to Inositec’s team as we enter IND/CTA-enabling studies with out lead programme in the vascular calcification space and fine-tune our clinical strategy in view of first-in-human studies in 2019.”

23rd January 2018

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics